View in EDS HTML Full Text PDF Full Text

Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis.

Saved in:
Bibliographic Details
Title: Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis.
Authors: Yang Y; Department of Oncology, Shaoyang Central Hospital, Shaoyang, Hunan, China.; First Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China., Sun J; First Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China., Luo T; Department of Respiratory Medicine,Shaoyang Central Hospital, Shaoyang, Hunan, China., Liu X; Department of Oncology, Shaoyang Central Hospital, Shaoyang, Hunan, China., Wang Y; Department of Radiation Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Source: Frontiers in oncology [Front Oncol] 2026 Jun 26; Vol. 16, pp. 1852617. Date of Electronic Publication: 2026 Jun 26 (Print Publication: 2026).
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42434745
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Department of Oncology, Shaoyang Central Hospital, Shaoyang, Hunan, China.; First Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China.<br /><searchLink fieldCode="AU" term="%22Sun+J%22">Sun J</searchLink>; First Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China.<br /><searchLink fieldCode="AU" term="%22Luo+T%22">Luo T</searchLink>; Department of Respiratory Medicine,Shaoyang Central Hospital, Shaoyang, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Department of Oncology, Shaoyang Central Hospital, Shaoyang, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Radiation Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Jun 26; Vol. 16, pp. 1852617. <i>Date of Electronic Publication: </i>2026 Jun 26 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42434745
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1852617
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1852617
    Titles:
      – TitleFull: Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Sun J
      – PersonEntity:
          Name:
            NameFull: Luo T
      – PersonEntity:
          Name:
            NameFull: Liu X
      – PersonEntity:
          Name:
            NameFull: Wang Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 06
              Text: 2026 Jun 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1